Modification of HDL3 by mild oxidative stress increases ATP-binding cassette transporter 1-mediated cholesterol efflux

Cardiovascular Research

Volumn 75, Issue 3, 2007, Pages 566-574

  Pirillo, Angela ^a   Uboldi, Patrizia ^a   Pappalardo, Gianluca ^a   Kuhn, Hartmut ^b   Catapano, Alberico L ^a  

^a Department of Pharmacological Sciences ^*  (Italy)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

15 lipoxygenase; ATP binding cassette transporter 1; High density lipoprotein; Oxidative stress; pre HDL; Reverse cholesterol transport

Indexed keywords

ABC TRANSPORTER A1; ARACHIDONATE 15 LIPOXYGENASE; CHOLESTEROL; COPPER; GLIBENCLAMIDE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN 3; UNCLASSIFIED DRUG; ABC TRANSPORTER; ANTIDIABETIC AGENT; PHOSPHOLIPID;

ANIMAL CELL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; FOAM CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PHOSPHOLIPID TRANSFER; PRIORITY JOURNAL; CELL LINE; DRUG EFFECT; FIBROBLAST; LIPID METABOLISM; MACROPHAGE; METABOLISM; PHYSIOLOGY; PROTEIN BINDING; TRANSPORT AT THE CELLULAR LEVEL;

ARACHIDONATE 15-LIPOXYGENASE; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CELL LINE; CHOLESTEROL; COPPER; FIBROBLASTS; GLYBURIDE; HUMANS; HYPOGLYCEMIC AGENTS; LIPID METABOLISM; LIPOPROTEINS, HDL3; MACROPHAGES; OXIDATIVE STRESS; PHOSPHOLIPIDS; PROTEIN BINDING;

EID: 34447498570     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2007.04.021     Document Type: Article

References (60)

1. Goldbourt U., Yaari S., and Medalie J.H. Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21-year follow-up of 8000 men. Arterioscler Thromb Vasc Biol 17 (1997) 107-113
2. Boden W.E. High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High-Density Lipoprotein Intervention Trial. Am J Cardiol 86 (2000) 19L-22L
3. Sharrett A.R., Ballantyne C.M., Coady S.A., Heiss G., Sorlie P.D., Catellier D., et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 104 (2001) 1108-1113
4. Rader D.J., and Maugeais C. Genes influencing HDL metabolism: new perspectives and implications for atherosclerosis prevention. Mol Med Today 6 (2000) 170-175
5. Stein O., and Stein Y. Atheroprotective mechanisms of HDL. Atherosclerosis 144 (1999) 285-301
6. Ishigami M., Yamashita S., Sakai N., Arai T., Hirano K., Hiraoka H., et al. Large and cholesteryl ester-rich high-density lipoproteins in cholesteryl ester transfer protein (CETP) deficiency can not protect macrophages from cholesterol accumulation induced by acetylated low-density lipoproteins. J Biochem (Tokyo) 116 (1994) 257-262
7. Castro G.R., and Fielding C.J. Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein. Biochemistry 27 (1988) 25-29
8. Huang Y., von Eckardstein A., and Assmann G. Cell-derived unesterified cholesterol cycles between different HDLs and LDL for its effective esterification in plasma. Arterioscler Thromb 13 (1993) 445-458
9. Barrans A., Jaspard B., Barbaras R., Chap H., Perret B., and Collet X. Pre-beta HDL: structure and metabolism. Biochim Biophys Acta 1300 (1996) 73-85
10. Yancey P.G., Bortnick A.E., Kellner-Weibel G., de la Llera-Moya M., Phillips M.C., and Rothblat G.H. Importance of different pathways of cellular cholesterol efflux. Arterioscler Thromb Vasc Biol 23 (2003) 712-719
11. Oram J.F. HDL apolipoproteins and ABCA1: partners in the removal of excess cellular cholesterol. Arterioscler Thromb Vasc Biol 23 (2003) 720-727
12. Wang N., and Tall A.R. Regulation and mechanisms of ATP-binding cassette transporter A1-mediated cellular cholesterol efflux. Arterioscler Thromb Vasc Biol 23 (2003) 1178-1184
13. Dixon J.L., and Ginsberg H.N. Hepatic synthesis of lipoproteins and apolipoproteins. Semin Liver Dis 12 (1992) 364-372
14. Danielsen E.M., Hansen G.H., and Poulsen M.D. Apical secretion of apolipoproteins from enterocytes. J Cell Biol 120 (1993) 1347-1356
15. Rye K.A., Clay M.A., and Barter P.J. Remodelling of high density lipoproteins by plasma factors. Atherosclerosis 145 (1999) 227-238
16. Hara H., and Yokoyama S. Interaction of free apolipoproteins with macrophages. Formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol. J Biol Chem 266 (1991) 3080-3086
17. Bielicki J.K., Johnson W.J., Weinberg R.B., Glick J.M., and Rothblat G.H. Efflux of lipid from fibroblasts to apolipoproteins: dependence on elevated levels of cellular unesterified cholesterol. J Lipid Res 33 (1992) 1699-1709
18. Miida T., Nakamura Y., Inano K., Matsuto T., Yamaguchi T., Tsuda T., et al. Pre beta 1-high-density lipoprotein increases in coronary artery disease. Clin Chem 42 (1996) 1992-1995
19. Miida T., Ozaki K., Murakami T., Kashiwa T., Yamadera T., Tsuda T., et al. Prebeta1-high-density lipoprotein (prebeta1-HDL) concentration can change with low-density lipoprotein-cholesterol (LDL-C) concentration independent of cholesteryl ester transfer protein (CETP). Clin Chim Acta 292 (2000) 69-80
20. Sugano M., Makino N., and Yanaga T. Effects of hepatic HDL-related mRNAs on plasma pre-beta HDL in cholesterol-fed rabbits. Artery 22 (1997) 182-205
21. Rifici V.A., and Khachadurian A.K. Oxidation of high density lipoproteins: characterization and effects on cholesterol efflux from J774 macrophages. Biochim Biophys Acta 1299 (1996) 87-94
22. Marsche G., Hammer A., Oskolkova O., Kozarsky K.F., Sattler W., and Malle E. Hypochlorite-modified high density lipoprotein, a high affinity ligand to scavenger receptor class B, type I, impairs high density lipoprotein-dependent selective lipid uptake and reverse cholesterol transport. J Biol Chem 277 (2002) 32172-32179
23. Suc I., Brunet S., Mitchell G., Rivard G.E., and Levy E. Oxidative tyrosylation of high density lipoproteins impairs cholesterol efflux from mouse J774 macrophages: role of scavenger receptors, classes A and B. J Cell Sci 116 (2003) 89-99
24. Cai H., and Harrison D.G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87 (2000) 840-844
25. Harrison D., Griendling K.K., Landmesser U., Hornig B., and Drexler H. Role of oxidative stress in atherosclerosis. Am J Cardiol 91 (2003) 7A-11A
26. Napoli C., de Nigris F., and Palinski W. Multiple role of reactive oxygen species in the arterial wall. J Cell Biochem 82 (2001) 674-682
27. Kuhn H., Heydeck D., Hugou I., and Gniwotta C. In vivo action of 15-lipoxygenase in early stages of human atherogenesis. J Clin Invest 99 (1997) 888-893
28. Funk C.D., and Cyrus T. 12/15-lipoxygenase, oxidative modification of LDL and atherogenesis. Trends Cardiovasc Med 11 (2001) 116-124
29. Chisolm III G.M., Hazen S.L., Fox P.L., and Cathcart M.K. The oxidation of lipoproteins by monocytes-macrophages. Biochemical and biological mechanisms. J Biol Chem 274 (1999) 25959-25962
30. Pirillo A., Uboldi P., Kuhn H., and Catapano A.L. 15-Lipoxygenase-mediated modification of high-density lipoproteins impairs SR-BI-and ABCA1-dependent cholesterol efflux from macrophages. Biochim Biophys Acta 1761 (2006) 292-300
31. Shen J., Herderick E., Cornhill J.F., Zsigmond E., Kim H.S., Kuhn H., et al. Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development. J Clin Invest 98 (1996) 2201-2208
32. Trebus F., Heydeck D., Schimke I., Gerth C., and Kuhn H. Transient experimental anemia in cholesterol-fed rabbits induces systemic overexpression of the reticulocyte-type 15-lipoxygenase and protects from aortic lipid deposition. Prostaglandins Leukot Essent Fatty Acids 67 (2002) 419-428
33. Cathcart M.K., and Folcik V.A. Lipoxygenases and atherosclerosis: protection versus pathogenesis. Free Radic Biol Med 28 (2000) 1726-1734
34. Belkner J., Stender H., and Kuhn H. The rabbit 15-lipoxygenase preferentially oxygenates LDL cholesterol esters, and this reaction does not require vitamin E. J Biol Chem 273 (1998) 23225-23232
35. Havel R.J., Eder H.A., and Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34 (1955) 1345-1353
36. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
37. Basu S.K., Goldstein J.L., Anderson G.W., and Brown M.S. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. Proc Natl Acad Sci U S A 73 (1976) 3178-3182
38. Repa J.J., Turley S.D., Lobaccaro J.A., Medina J., Li L., Lustig K., et al. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 289 (2000) 1524-1529
39. Smith J.D., Le Goff W., Settle M., Brubaker G., Waelde C., Horwitz A., et al. ABCA1 mediates concurrent cholesterol and phospholipid efflux to apolipoprotein A-I. J Lipid Res 45 (2004) 635-644
40. Wang N., Silver D.L., Thiele C., and Tall A.R. ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein. J Biol Chem 276 (2001) 23742-23747
41. Bertolini S., Pisciotta L., Seri M., Cusano R., Cantafora A., Calabresi L., et al. A point mutation in ABC1 gene in a patient with severe premature coronary heart disease and mild clinical phenotype of Tangier disease. Atherosclerosis 154 (2001) 599-605
42. Francis G.A., Oram J.F., Heinecke J.W., and Bierman E.L. Oxidative tyrosylation of HDL enhances the depletion of cellular cholesteryl esters by a mechanism independent of passive sterol desorption. Biochemistry 35 (1996) 15188-15197
43. Macdonald D.L., Terry T.L., Agellon L.B., Nation P.N., and Francis G.A. Administration of tyrosyl radical-oxidized HDL inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 23 (2003) 1583-1588
44. Bergt C., Oram J.F., and Heinecke J.W. Oxidized HDL: the paradox-idation of lipoproteins. Arterioscler Thromb Vasc Biol 23 (2003) 1488-1490
45. Ohara Y., Peterson T.E., and Harrison D.G. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 91 (1993) 2546-2551
46. Kumar S.A., Sudhahar V., and Varalakshmi P. Oxidative renal injury and lipoprotein oxidation in hypercholesterolemic atherogenesis: Role of eicosapentaenoate-lipoate (EPA-LA) derivative. Prostaglandins Leukot Essent Fatty Acids 75 (2006) 25-31
47. Griendling K.K., Sorescu D., Lassegue B., and Ushio-Fukai M. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol 20 (2000) 2175-2183
48. Fukai T., Siegfried M.R., Ushio-Fukai M., Griendling K.K., and Harrison D.G. Modulation of extracellular superoxide dismutase expression by angiotensin II and hypertension. Circ Res 85 (1999) 23-28
49. Visner G.A., Chesrown S.E., Monnier J., Ryan U.S., and Nick H.S. Regulation of manganese superoxide dismutase: IL-1 and TNF induction in pulmonary artery and microvascular endothelial cells. Biochem Biophys Res Commun 188 (1992) 453-462
50. Swain J., and Gutteridge JM. Prooxidant iron and copper, with ferroxidase and xanthine oxidase activities in human atherosclerotic material. FEBS Lett 368 (1995) 513-515
51. Steinberg D. At last, direct evidence that lipoxygenases play a role in atherogenesis. J Clin Invest 103 (1999) 1487-1488
52. Sun D., and Funk C.D. Disruption of 12/15-lipoxygenase expression in peritoneal macrophages. Enhanced utilization of the 5-lipoxygenase pathway and diminished oxidation of low density lipoprotein. J Biol Chem 271 (1996) 24055-24062
53. Cyrus T., Pratico D., Zhao L., Witztum J.L., Rader D.J., Rokach J., et al. Absence of 12/15-lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein e-deficient mice. Circulation 103 (2001) 2277-2282
54. Sigalov A.B., and Stern L.J. Oxidation of methionine residues affects the structure and stability of apolipoprotein A-I in reconstituted high density lipoprotein particles. Chem Phys Lipids 113 (2001) 133-146
55. Fournier N., Francone O., Rothblat G., Goudouneche D., Cambillau M., Kellner-Weibel G., et al. Enhanced efflux of cholesterol from ABCA1-expressing macrophages to serum from type IV hypertriglyceridemic subjects. Atherosclerosis 171 (2003) 287-293
56. Stokes K.Y., Cooper D., Tailor A., and Granger D.N. Hypercholesterolemia promotes inflammation and microvascular dysfunction: role of nitric oxide and superoxide. Free Radic Biol Med 33 (2002) 1026-1036
57. Williams K.J., and Fisher E.A. Oxidation, lipoproteins, and atherosclerosis: which is wrong, the antioxidants or the theory?. Curr Opin Clin Nutr Metab Care 8 (2005) 139-146
58. Kuller L.H. A time to stop prescribing antioxidant vitamins to prevent and treat heart disease?. Arterioscler Thromb Vasc Biol 21 (2001) 1253
59. Brown B.G., Cheung M.C., Lee A.C., Zhao X.Q., and Chait A. Antioxidant vitamins and lipid therapy: end of a long romance?. Arterioscler Thromb Vasc Biol 22 (2002) 1535-1546
60. Zureik M., Galan P., Bertrais S., Mennen L., Czernichow S., Blacher J., et al. Effects of long-term daily low-dose supplementation with antioxidant vitamins and minerals on structure and function of large arteries. Arterioscler Thromb Vasc Biol 24 (2004) 1485-1491